Spelling suggestions: "subject:"plantlets"" "subject:"printades""
1 |
3D printed drug products: Non-destructive dose verification using a rapid point-and-shoot approachTrenfield, S.J., Goyanes, A., Telford, Richard, Wilsdon, D., Rowland, M., Gaisford, S., Basit, A.W. 02 August 2018 (has links)
Yes / Three-dimensional printing (3DP) has the potential to cause a paradigm shift in the manufacture of pharmaceuticals, enabling personalised medicines to be produced on-demand. To facilitate integration into healthcare, non-destructive characterisation techniques are required to ensure final product quality. Here, the use of process analytical technologies (PAT), including near infrared spectroscopy (NIR) and Raman confocal microscopy, were evaluated on paracetamol-loaded 3D printed cylindrical tablets composed of an acrylic polymer (Eudragit L100-55). Using a portable NIR spectrometer, a calibration model was developed, which predicted successfully drug concentration across the range of 4–40% w/w. The model demonstrated excellent linearity (R2 = 0.996) and accuracy (RMSEP = 0.63%) and results were confirmed with conventional HPLC analysis. The model maintained high accuracy for tablets of a different geometry (torus shapes), a different formulation type (oral films) and when the polymer was changed from acrylic to cellulosic (hypromellose, HPMC). Raman confocal microscopy showed a homogenous drug distribution, with paracetamol predominantly present in the amorphous form as a solid dispersion. Overall, this article is the first to report the use of a rapid ‘point-and-shoot’ approach as a non-destructive quality control method, supporting the integration of 3DP for medicine production into clinical practice. / Open Access funded by Engineering and Physical Sciences Research Council United Kingdom (EPSRC), UK for their financial support (EP/L01646X).
|
2 |
3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic MethodRobles-Martinez, P., Xu, X., Trenfield, S.J., Awad, A., Goyanes, A., Telford, Richard, Basit, A.W., Gaisford, S. 15 October 2019 (has links)
Yes / Three-dimensional printing (3DP) has demonstrated great potential for multi-material
fabrication because of its capability for printing bespoke and spatially separated material
conformations. Such a concept could revolutionise the pharmaceutical industry, enabling the
production of personalised, multi-layered drug products on demand. Here, we developed a novel
stereolithographic (SLA) 3D printing method that, for the first time, can be used to fabricate multi-layer
constructs (polypills) with variable drug content and/or shape. Using this technique, six drugs,
including paracetamol, cffeine, naproxen, chloramphenicol, prednisolone and aspirin, were printed
with dfferent geometries and material compositions. Drug distribution was visualised using Raman
microscopy, which showed that whilst separate layers were successfully printed, several of the drugs
diffused across the layers depending on their amorphous or crystalline phase. The printed constructs
demonstrated excellent physical properties and the different material inclusions enabled distinct drug
release profiles of the six actives within dissolution tests. For the first time, this paper demonstrates the
feasibility of SLA printing as an innovative platform for multi-drug therapy production, facilitating a
new era of personalised polypills.
|
3 |
Supramolecular chemistry enables vat photopolymerization 3D printing of novel water-soluble tabletsOng, J.J., Chow, Y.L., Gaisford, S., Cook, M.T., Swift, Thomas, Telford, Richard, Rimmer, Stephen, Qin, Y., Mai, Y., Goyanes, A., Basit, A.W. 12 December 2023 (has links)
Yes / Vat photopolymerization has garnered interest from pharmaceutical researchers for the fabrication of personalised medicines, especially for drugs that require high precision dosing or are heat labile. However, the 3D printed structures created thus far have been insoluble, limiting printable dosage forms to sustained-release systems or drug-eluting medical devices which do not require dissolution of the printed matrix. Resins that produce water-soluble structures will enable more versatile drug release profiles and expand potential applications. To achieve this, instead of employing cross-linking chemistry to fabricate matrices, supramolecular chemistry may be used to impart dynamic interaction between polymer chains. In this study, water-soluble drug-loaded printlets (3D printed tablets) are fabricated via digital light processing (DLP) 3DP for the first time. Six formulations with varying ratios of an electrolyte acrylate …
|
Page generated in 0.0403 seconds